Julie Miller Everett
Analyst
Equibles does not estimate personal net worth.
About Julie Miller Everett
Julie Miller Everett has spoken on 1 investor event across 1 company, most recently for BridgeBio Pharma, Inc. on June 9, 2026. The companies whose calls Julie Miller Everett spoke on are classified in the Healthcare sector.
Julie Miller Everett on recent calls
“So I think for us, we anticipate it being a little bit more even moving forward between U.S. and ex-US. And part of that, if you take a look at the U.S. market specifically, We know that there's about 3,400 patients that are eligible, pediatric patients eligible with open epithesis for therapy.”